Pulmonary TB — Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults
Citation(s)
A Phase 1, Double-Blind, Randomized Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the Single-Vial Lyophilized ID93 + GLA-SE Vaccine Administered Intramuscularly in Healthy Adult Subjects